Trevena, Inc. (TRVN) CEO Carrie Bourdow on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/09/21
Trevena to Release Fourth Quarter and Full Year 2020 Financial Results on March 9, 2021GlobeNewsWire • 03/05/21
Trevena, Inc. Announces Publication Highlighting OLINVYK™ Respiratory Safety Data in High-Risk Patients in Pain & TherapyGlobeNewsWire • 01/28/21
Trevena, Inc. Announces Presentations Highlighting Novel S1P1 Receptor Modulator at the American College of Neuropsychopharmacology 59th Annual MeetingGlobeNewsWire • 12/10/20
Trevena, Inc. Announces Publication Highlighting GI Tolerability Profile of OLINVYK™ (oliceridine) injection in Pain and TherapyGlobeNewsWire • 11/20/20
Trevena, Inc. to Participate in the Following November Virtual Investor ConferencesGlobeNewsWire • 11/09/20
Trevena, Inc. Announces Three OLINVYK™ Presentations at the Virtual American Society of Anesthesiologists 2020 Annual MeetingGlobeNewsWire • 10/05/20
Trevena, Inc. Announces Presentations at the Virtual 2020 American College of Clinical Pharmacology Annual MeetingGlobeNewsWire • 09/21/20
Is the Options Market Predicting a Spike in Trevena (TRVN) Stock?Zacks Investment Research • 09/18/20
Trevena: Strong Buy After Opioid Approval And Potential Supplementary COVID-19 ValueSeeking Alpha • 08/31/20
Trevena Announces Publications of OLINVYK™ Respiratory Safety Analyses vs. IV MorphineGlobeNewsWire • 08/26/20
Trevena Announces Initiation of TRV027 Study in COVID-19 Patients in Collaboration With Imperial College LondonGlobeNewsWire • 08/24/20
Trevena Announces Receipt of Milestone Payment Under Partnership in China With Jiangsu Nhwa Pharmaceutical Co.GlobeNewsWire • 08/20/20